OKYO Pharma Ltd (OKYO) stock
OKYONasdaqBiological Products, (No Diagnostic Substances)
$1.11−0.06 (-5.13%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
OKYO Pharma net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for OKYO Pharma
OKYO Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?